Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar
Corrected Proof scheduled for 12 (4)

Prevalence of Depression and Its Affecting Factors in Patients Referred to Substance Abuse Treatment Centers in Guilan Province, Iran, During Year 2013

Mohammad Hassan Novin 1 , * , Hassan Eftekhar-Ardebili 2 , Azizollah Batebi 2 , Zahra Mohtasham Amiri 3 and Nahid Bazarganian Langeroodi 4
Authors Information
1 School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
2 School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
3 Department of Community Medicine, School of Medicine, Guilan University, Rasht, Iran
4 Health Center of Guilan, Guilan University of Medical Sciences, Rasht, Iran
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: In Press (In Press); e58779
  • Published Online: September 29, 2018
  • Article Type: Original Article
  • Received: July 25, 2017
  • Revised: February 14, 2018
  • Accepted: July 15, 2018
  • DOI: 10.5812/ijpbs.58779

To Cite: Novin M H, Eftekhar-Ardebili H , Batebi A , Mohtasham Amiri Z , Bazarganian Langeroodi N . et al. Prevalence of Depression and Its Affecting Factors in Patients Referred to Substance Abuse Treatment Centers in Guilan Province, Iran, During Year 2013, Iran J Psychiatry Behav Sci. Online ahead of Print ; In Press(In Press):e58779. doi: 10.5812/ijpbs.58779.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Nutt DJ, King LA, Phillips LD, Independent Scientific Committee on D. Drug harms in the UK: A multicriteria decision analysis. Lancet. 2010;376(9752):1558-65. doi: 10.1016/S0140-6736(10)61462-6. [PubMed: 21036393].
  • 2. Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, et al. Common values in assessing health outcomes from disease and injury: Disability weights measurement study for the global burden of disease study 2010. Lancet. 2012;380(9859):2129-43. doi: 10.1016/S0140-6736(12)61680-8. [PubMed: 23245605].
  • 3. Rossi Menezes P, Ratto LR. Prevalence of substance misuse among individuals with severe mental illness in Sao Paulo. Soc Psychiatry Psychiatr Epidemiol. 2004;39(3):212-7. doi: 10.1007/s00127-004-0730-z. [PubMed: 14999454].
  • 4. Lai HM, Cleary M, Sitharthan T, Hunt GE. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: A systematic review and meta-analysis. Drug Alcohol Depend. 2015;154:1-13. doi: 10.1016/j.drugalcdep.2015.05.031. [PubMed: 26072219].
  • 5. Tolliver BK, Anton RF. Assessment and treatment of mood disorders in the context of substance abuse. Dialogues Clin Neurosci. 2015;17(2):181-90. [PubMed: 26246792]. [PubMed Central: PMC4518701].
  • 6. Farhadi Nasab AA, Manikashani KH. [Substitution therapy with Methadone and evaluation of depression in drug users in Hamadan]. SJIMU. 2008;16(2):44-50. Persian.
  • 7. Poorolajal J, Ghaleiha A, Darvishi N, Daryaei S, Panahi S. The prevalence of psychiatric distress and associated risk factors among college students using GHQ-28 questionnaire. Iran J Public Health. 2017;46(7):957-63. [PubMed: 28845407]. [PubMed Central: PMC5563878].
  • 8. Tran BX, Nguyen LH, Nong VM, Nguyen CT, Phan HT, Latkin CA. Behavioral and quality-of-life outcomes in different service models for methadone maintenance treatment in Vietnam. Harm Reduct J. 2016;13:4. doi: 10.1186/s12954-016-0091-4. [PubMed: 26837193]. [PubMed Central: PMC4736621].
  • 9. Dolan K, Salimi S, Nassirimanesh B, Mohsenifar S, Allsop D, Mokri A. Characteristics of Iranian women seeking drug treatment. J Womens Health (Larchmt). 2011;20(11):1687-91. doi: 10.1089/jwh.2010.2694. [PubMed: 21905877].
  • 10. Abbasi A, Taziki SA, Moradi M. [The prototype of drug mis.abused of opioids in the self-introduced addicts in Gorgan (North-East of Iran)]. J Gorgan Unci Med. 2006;1:22-7. Persian.
  • 11. Parvizi Fard A, Birashk B, Atefvahid MK, Shakeri J. [Comorbidity of and substance abuse among treatment-seeking addicts and normal individuals]. IJPCP. 2001;7(1 and 2):45-55. Persian.
  • 12. Ahmadvand A, Sepehrmanesh Z, Ghoreyshi F, Assarian F, Moosavi G, Saee R, et al. Prevalence of mental disorders in general population of Kashan City. Iran J Epidemiol. 2010;6(2):16-24. Persian.
  • 13. Gharagozlou H, Behin MT. Frequency of psychiatric symptoms among 150 opium addicts in Shiraz, Iran. Int J Addict. 1979;14(8):1145-9. [PubMed: 536060].
  • 14. Hosseini S, Taghipour M, Tavakkoli M, Hamta A. Demographic features of patients in methadone maintenance treatment, referred to private Mmt clinic, Sari-Iran (2009-2010). Shiraz E Med J. 2012;13(3):128-34.
  • 15. Mortazavi SS, Shati M, Malakouti SK, Mohammad K. Psychiatric comorbidities among Iranian elderly patients on methadone maintenance treatment. Arch Iran Med. 2015;18(11):740-6. [PubMed: 26497370].
  • 16. Eslami-Shahrbabaki M, Fekrat A, Mazhari S. A Study of the prevalence of psychiatric disorders in patients with methamphetamine-induced psychosis. Addict Health. 2015;7(1-2):37-46. [PubMed: 26322209]. [PubMed Central: PMC4530192].
  • 17. Pani PP, Vacca R, Trogu E, Amato L, Davoli M. Pharmacological treatment for depression during opioid agonist treatment for opioid dependence. Cochrane Database Syst Rev. 2010;(9). CD008373. doi: 10.1002/14651858.CD008373.pub2. [PubMed: 20824876].
  • 18. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61(8):807-16. doi: 10.1001/archpsyc.61.8.807. [PubMed: 15289279].
  • 19. Peles E, Schreiber S, Naumovsky Y, Adelson M. Depression in methadone maintenance treatment patients: Rate and risk factors. J Affect Disord. 2007;99(1-3):213-20. doi: 10.1016/j.jad.2006.09.017. [PubMed: 17055063].
  • 20. Teesson M, Slade T, Mills K. Comorbidity in Australia: Findings of the 2007 national survey of mental health and wellbeing. Aust N Z J Psychiatry. 2009;43(7):606-14. doi: 10.1080/00048670902970908. [PubMed: 19530017].
  • 21. Mason BJ, Kocsis JH, Melia D, Khuri ET, Sweeney J, Wells A, et al. Psychiatric comorbidity in methadone maintained patients. J Addict Dis. 1998;17(3):75-89. doi: 10.1300/J069v17n03_07. [PubMed: 9789161].
  • 22. Kosten TR, Rounsaville BJ, Kleber HD. Predictors of 2.5-year outcome in opioid addicts: Pretreatment source of income. Am J Drug Alcohol Abuse. 1987;13(1-2):19-32. [PubMed: 3687883].
  • 23. Todadze K, Mosia S. Dynamics of opioid substitution treatmentin different initial substance user opioid dependent patients. Georgian Med News. 2016;(254):56-61. [PubMed: 27348169].
  • 24. Shi J, Zhao LY, Epstein DH, Zhao C, Shuai Y, Yan B, et al. The effect of methadone maintenance on illicit opioid use, human immunodeficiency virus and hepatitis C virus infection, health status, employment, and criminal activity among heroin abusers during 6 months of treatment in china. J Addict Med. 2007;1(4):186-90. doi: 10.1097/ADM.0b013e318156cc19. [PubMed: 21768956].
  • 25. Momtaz A, Hatami H, Noorzadeh M, Saiah Bargard M, Saki S, Shirazi Beheshti ST. The effectiveness of methadone maintenance treatment in the reduction of anxiety and depression among drug-related prisoners. Jundishapur J Health Sci. 2014.
  • 26. Yin W, Pang L, Cao X, McGoogan JM, Liu M, Zhang C, et al. Factors associated with depression and anxiety among patients attending community-based methadone maintenance treatment in China. Addiction. 2015;110 Suppl 1:51-60. doi: 10.1111/add.12780. [PubMed: 25533864].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments